People in Texas who have used Zantac may be interested to learn that the makers of the drug are being sued. There are currently thousands of pending lawsuits filed by people all over the country who are saying that Zantac, an antacid drug, caused their cancer.
Date set for first Zantac pretrial
So far, just one Zantac case has an official pretrial date. A California state court will hear the class action lawsuit beginning on Oct. 10, 2022. Plaintiffs that may qualify to join the proceeding, called the “Ranitidine Product Cases,” in California may still file their lawsuit. Similar proceedings are ongoing in other states, including Texas.
Other trials may be scheduled soon
While the California case is the first Zantac lawsuit with an official pretrial date, other cases may be scheduled soon. These cases could possibly have dates earlier than October 2022. For example, some plaintiffs in Tennessee have requested a trial for Spring 2022, but it has not been scheduled yet.
What cancers are linked to Zantac?
Zantac is the product name for the generic drug ranitidine. It was commonly used for heartburn and was available over the counter or by prescription. Plaintiffs have claimed that, after taking Zantac, they were diagnosed with several different types of cancer, including:
- Breast cancer
- Stomach cancer
- Prostate cancer
- Lung cancer without smoking
- Kidney cancer
- Liver cancer
- Bladder cancer
- Thyroid cancer
- Esophageal cancer
According to one of the lawyers involved in the trials, the Zantac lawsuits could be bigger than the litigation over Monsanto’s Roundup. Defective products sold by Monsanto have resulted in billions of dollars in settlements.